Researchers’ warnings about ‘wonder drug’ top oncology stories for February

News about potential negative consequences when prescribing metformin for cancer patients was Becker’s most-read oncology story in February. 

Advertisement

The top 10 most-read oncology stories published by Becker’s Hospital Review last month, starting with the most popular:

1. ‘Wonder drug’ metformin not a treatment for all cancer types, researchers caution

2. CAR-T therapy recipients cancer-free after a decade, researchers find

3. MD Anderson receives $31.7M from research institute 

4. St. Joseph’s, Hackensack Meridian Health affiliation tops January oncology stories

5. Biden revives Cancer Moonshot program 

6. 6 oncologists on the move

7. 4 oncologists on the move

8. MD Anderson renews Banner Health partnership

9. 5 recent cancer partnerships

10. Oncologists respond to 2021 malpractice survey: 5 findings

At the Becker's Perioperative Summit, taking place September 14–15 in Chicago, perioperative leaders and healthcare executives will focus on improving operating room efficiency, enhancing patient safety, optimizing staffing and driving innovation across surgical services. Apply for complimentary registration now.

Advertisement

Next Up in Oncology

Advertisement